z-logo
open-access-imgOpen Access
Asynchronous Remote Assessment for Cognitive Impairment: Reliability Verification of the Neurotrack Cognitive Battery
Author(s) -
Jennifer Rae Myers,
Jordan M. Glenn,
Erica N. Madero,
John J.B. Anderson,
Rachel MakMcCully,
Michelle Gray,
Joshua L. Gills,
John Harrison
Publication year - 2022
Publication title -
jmir formative research
Language(s) - English
Resource type - Journals
ISSN - 2561-326X
DOI - 10.2196/34237
Subject(s) - intraclass correlation , reliability (semiconductor) , cognitive assessment system , cognition , audiology , cognitive test , psychology , cognitive impairment , medicine , psychometrics , clinical psychology , psychiatry , power (physics) , physics , quantum mechanics
Background As evidenced by the further reduction in access to testing during the COVID-19 pandemic, there is an urgent, growing need for remote cognitive assessment for individuals with cognitive impairment. The Neurotrack Cognitive Battery (NCB), our response to this need, was evaluated for its temporal reliability and stability as part of ongoing validation testing. Objective The aim of this study is to assess the temporal reliability of the NCB tests (5 total) across a 1-week period and to determine the temporal stability of these measures across 3 consecutive administrations in a single day. Methods For test-retest reliability, a range of 29-66 cognitively healthy participants (ages 18-68 years) completed each cognitive assessment twice, 1 week apart. In a separate study, temporal stability was assessed using data collected from 31 different cognitively healthy participants at 3 consecutive timepoints in a single day. Results Correlations for the assessments were between 0.72 and 0.83, exceeding the standard acceptable threshold of 0.70 for temporal reliability. Intraclass correlations ranged from 0.60 to 0.84, indicating moderate to good temporal stability. Conclusions These results highlight the NCB as a brief, easy-to-administer, and reliable assessment for remote cognitive testing. Additional validation research is underway to determine the full magnitude of the clinical utility of the NCB.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here